prof_pic.jpg

Ting Zhai

Ph.D. Candidate at Harvard University

655 Huntington Ave, Boston, MA 02115

Research: I am a Ph.D. candidate in Population Health Sciences at Harvard University, advised by Dr. Zachary Nagel and committee members Drs. David Christiani and Liming Liang. My research integrates functional assays, multi-omics data, longitudinal cohorts, and advanced statistical modeling to develop biomarkers and decision tools that support precision health across the lifecourse, from the general population to high-risk and vulnerable subgroups, and in clinical contexts (more on my dissertation). My work spans:

  • Genome Integrity & DNA Repair: DNA repair mechanisms, telomere biology, and mutational processes shaping cancer susceptibility, treatment response, and inter-individual variability.
  • Integrative Omics & Functional Assays: WGS/WES, DNA methylation, RNA-seq, and novel functional repair assays and computational pipelines for mechanistic insight and population-scale applications.
  • Computational & Statistical Methods: Bayesian modeling, causal inference, longitudinal/survival analysis, and machine learning to link molecular features with health outcomes.
  • Precision Health & Lifecourse Outcomes: Molecular and phenotypic predictors of therapy response, prognosis, and aging trajectories to inform both personalized oncology and preventive strategies in populations.

Looking ahead, my goal is to advance precision health across the lifecourse by integrative omic dynamics and causal population analytics to identify molecular features that are both biologically meaningful and actionable. My long-term aim is to translate these insights into simple, scalable tools for disease prevention, early detection, and personalized intervention in both general populations and vulnerable subgroups.

Previously, I earned my M.S. in Epidemiology at the Harvard T.H. Chan School of Public Health, where I was advised by Dr. David Christiani. My master’s research examined pulmonary function as a predictor of long-term survival among lung cancer patients, leveraging electronic health record (EHR) data from the Boston Lung Cancer Study. Before that, I obtained my MBBS in Preventive Medicine from Qingdao Univerisity, gaining a comprehensive foundation in clinical and occupational medicine, endocrinology and metabolism, and public health under the mentorship of Dr. Shuguang Leng and Dr. Jing Dong.

selected publications

  1. advs.png
    Comprehensive Measurement of Inter-Individual Variation in DNA Repair Capacity in Healthy Individuals
    Ting Zhai, Patrizia Mazzucato, Catherine Ricciardi, David C. Christiani, Liming Liang, Leona D. Samson, Isaac A. Chaim, and Zachary D. Nagel
    Advanced Science, 2025
  2. msi.png
    MSIanalyzer: Targeted Nanopore Sequencing Enables Single Nucleotide Resolution Analysis of Microsatellite Instability Diversity
    Ting Zhai, Daniel J. Laverty, and Zachary D. Nagel
    bioRxiv, 2025
  3. cam2.png
    Residual Volume and Total Lung Capacity at Diagnosis Predict Overall Survival in Non‐Small Cell Lung Cancer Patients
    Ting Zhai, Yi Li, Robert Brown, Michael Lanuti, Justin F. Gainor, and David C. Christiani
    Cancer Medicine, 2025
  4. jes.png
    Annual space weather fluctuations and telomere length in the Normative Aging Study
    Ting Zhai, Carolina L. Zilli Vieira, Pantel Vokonas, Andrea A. Baccarelli, Zachary D. Nagel, Joel Schwartz, and Petros Koutrakis
    Journal of Exposure Science & Environmental Epidemiology, 2023
  5. ajog.png
    Early natural menopause is associated with poor lung health and increased mortality among female smokers
    Ting Zhai, Brenda Diergaarde, David O. Wilson, Huining Kang, Akshay Sood, Samuel H. Bayliss, Jian-Min Yuan, Maria A. Picchi, Qing Lan, Steven A. Belinsky, Jill M. Siegfried, Linda S. Cook, and Shuguang Leng
    American Journal of Obstetrics & Gynecology, 2022